Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 2301-2320 of 2,724 trials

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NCT00806546

This study will use an open-label design to evaluate the safety of NP101. Adult subjects who meet the enrollment criteria will be treated with NP101 (sumatriptan succinate iontophoretic transdermal patch) for acute migraine attacks over a 12 month period.

Migraine Disorders

NuPathe Inc.514 participantsStarted Feb 2009

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Irvine, California, United States +28 more locations

COMPLETEDPhase 3< 1 mile

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

NCT00724815

This study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch. The primary objective of this study was to assess the proportion of subjects who were headache pain free at two hours after patch activation. Key secondary objectives included: 1. The proportion of subjects who were nausea free at two hours after patch activation. 2. The proportion of subjects who were photophobia free at two hours after patch activation. 3. The proportion of subjects who were phonophobia free at two hours after patch activation.

Migraine Disorders

NuPathe Inc.530 participantsStarted Jan 2009

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Newport Beach, California, United States +31 more locations

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Rheumatoid Arthritis Trials in Other Cities

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Tolerance of Healthy Infants Fed Infant Formulas

Prehospital Resuscitation On Helicopter Study

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)

Association of Amino Acid Prevalence and Chronic Brain Injury

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

Other Conditions in Phoenix